ClinicalTrials.Veeva

Menu

Predictive Model on the Effect of Lifestyles in the Management of T2D (GK_T2D)

C

Casa Sollievo della Sofferenza IRCCS

Status

Active, not recruiting

Conditions

Type 2 Diabetes

Treatments

Other: Standard care for T2D patients, Smartwatch

Study type

Observational

Funder types

Other

Identifiers

NCT05261841
GATEKEEPER-V1.6_03 DIC 2020

Details and patient eligibility

About

This study aims to produce new evidence on the positive effects of physical activity and certain individual lifestyles in the control of type 2 diabetic disease. The goal is to build and evaluate the effectiveness of a new parsimonious risk prediction model based on the use of classical variables (blood exams), already used in other models for predicting the risk related to the disease, together with measures obtained from the use of wearable devices (steps count, sleep hours, heart rate).

Full description

Scientific literature has shown that the use of wearable devices can improve the control of type 2 diabetes mellitus. The aim of the study is to develop a statistical model for the control of type 2 diabetes mellitus (DMT2) based on the use of "conventional" clinical parameters and the use of "unconventional" data from wearable devices. The medical outcome variable that will be used to measure diabetes control and model performance will be the Glycated Hemoglobin (HbA1c). The participant will receive a Samsung smartwatch (Galaxy Watch 3) and a Samsung smartphone (A51), (the latter only in case the participant is not in possession of a compatible smartphone) which he/she must wear during his daily activities and also during the night to measure daily activity, sleep hours and heart rate. Casa Sollievo della Sofferenza Hospital previoulsy developted the ENFORCE calculator, an inexpensive and parsimonious prediction model of 2-year all cause mortality in real life patients with T2D. In this study the investigators aim to elaborate a standardized validated risk scores similar to what has been done for ENFORCE.

Enrollment

100 patients

Sex

All

Ages

55 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 55 years old
  • Affected by Type 2 Diabetes and monitored by Casa Sollievo della Sofferenza Hospital
  • Basic skills in using a smartphone and its apps
  • Available to use the device and its applications
  • Ability to understand the informed consent

Exclusion criteria

  • Inability to understand the informed consent
  • Low life expectancy
  • Type 1 Diabetes
  • Secondary Diabetes

Trial design

100 participants in 1 patient group

TYPE 2 DIABETES
Description:
Patients affected by type 2 diabetes
Treatment:
Other: Standard care for T2D patients, Smartwatch

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems